Skip to main content
Clinical Trials/NCT07339501
NCT07339501CompletedNot Applicable

Cystic Artery Preservation : an Additional Step for Safe Laparoscopic Cholecystectomy

Suez University1 site in 1 country200 target enrollmentStarted: August 12, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Patients will be followed up by Abdominal ultrasound for post operative abdominal collection

Study Overview

Brief Summary

Our aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Participant)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 1-Patients with symptomatic gall bladder stones. 2-Patients with normal coagulation profile.

Exclusion Criteria

  • 1- Patients with hepatic co-morbidity especially (cirrhosis). 2-Patients with previous upper abdominal surgery.

Arms & Interventions

group (A)

Active Comparator

Intervention: The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a (Procedure)

group B

Placebo Comparator

Intervention: The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery (Procedure)

Outcomes

Primary Outcomes

Patients will be followed up by Abdominal ultrasound for post operative abdominal collection

Time Frame: one month

Follow up with ultrasound to evaluate if there's bleeding or not after preserving the cystic artery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Suez University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmad Ali Maklad

lecturer of general surgery

Suez University

Study Sites (1)

Loading locations...

Similar Trials